Wordt geladen...
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
[Image: see text] We report the discovery of a new potent allosteric effector of sickle cell hemoglobin, GBT440 (36), that increases the affinity of hemoglobin for oxygen and consequently inhibits its polymerization when subjected to hypoxic conditions. Unlike earlier allosteric activators that bind...
Bewaard in:
| Gepubliceerd in: | ACS Med Chem Lett |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Chemical
Society
2017
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346980/ https://ncbi.nlm.nih.gov/pubmed/28337324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00491 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|